Average Insider

Where insiders trade, we follow

SpyGlass Pharma, Inc. Common Stock ($SGP)
Accession: 0001193125-26-045028
Feb 10, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$20.16
Current$29.1373.0% above low, 27.0% below high
52W High$32.44

Filing Information

Accession Number0001193125-26-045028
Form Type4
Filing DateFeb 10, 2026
Document DateFeb 9, 2026
DocumentView SEC Filing
Transactions
9
Total Shares
21,344,144
Total Value
$2,640,000.00
P&L
+82.1% (+$2,166,450.00)

Transactions

NameTitleSecurityDerivativeTransaction DateTypeSharesPriceTotal CostShares AfterDirect/IndirectNature of OwnershipActions
Vensana Capital I GP, LLC
10% Owner
Common Stock
โ€”Feb 9, 2026Conversion1,690,230โ€”โ€”1,690,230IndirectSee footnoteView Details
Vensana Capital I GP, LLC
10% Owner
Common Stock
โ€”Feb 9, 2026Conversion548,067โ€”โ€”2,238,297IndirectSee footnoteView Details
Vensana Capital I GP, LLC
10% Owner
Common Stock
โ€”Feb 9, 2026Conversion548,067โ€”โ€”2,786,364IndirectSee footnoteView Details
Vensana Capital I GP, LLC
10% Owner
Common Stock
โ€”Feb 9, 2026Conversion359,255โ€”โ€”3,145,619IndirectSee footnoteView Details
Vensana Capital I GP, LLC
10% Owner
Common Stock
โ€”Feb 9, 2026Purchase165,000$16.00$2,640,000.003,310,619IndirectSee footnoteView Details
Vensana Capital I GP, LLC
10% Owner
Series B Preferred Stock
(Common Stock)
DerivativeFeb 9, 2026Conversion9,689,922โ€”โ€”0IndirectSee FootnoteView Details
Vensana Capital I GP, LLC
10% Owner
Series C-1 Preferred Stock
(Common Stock)
DerivativeFeb 9, 2026Conversion3,142,015โ€”โ€”0IndirectSee FootnoteView Details
Vensana Capital I GP, LLC
10% Owner
Series C-2 Preferred Stock
(Common Stock)
DerivativeFeb 9, 2026Conversion3,142,015โ€”โ€”0IndirectSee FootnoteView Details
Vensana Capital I GP, LLC
10% Owner
Series D Preferred Stock
(Common Stock)
DerivativeFeb 9, 2026Conversion2,059,573โ€”โ€”0IndirectSee FootnoteView Details
Version: v26.3.23